Biopol Chemicals Limited (NSE:BIOPOL)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024
Speciality Chemiclas	813.72M	491.28M	174.33M
Speciality Chemiclas Growth	65.63%	181.82%	-
Total	813.72M	491.28M	174.33M
Total Growth	65.63%	181.82%	-

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024
Period Ending	Mar 31, 2025	Mar 31, 2024
India	454.38M	238.02M
India Growth	90.90%	-
Bangladesh	36.91M	16.68M
Bangladesh Growth	121.28%	-
Total	491.28M	254.70M
Total Growth	92.89%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 22, 2026

Data Sources Report a data error